SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EBF1
|
ENSG00000164330.12 | EBF transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EBF1 | hg19_v2_chr5_-_158526693_158526706 | -0.69 | 7.7e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_37640277 | 9.46 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr22_-_37640456 | 8.96 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr19_+_35606777 | 6.20 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr17_-_39781054 | 5.98 |
ENST00000463128.1
|
KRT17
|
keratin 17 |
chr17_-_39780634 | 5.29 |
ENST00000577817.2
|
KRT17
|
keratin 17 |
chr14_+_23305760 | 5.11 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
chr17_-_39780819 | 4.86 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
chr19_+_35607166 | 4.76 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr16_-_68269971 | 4.65 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
chr15_+_41136586 | 4.44 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chrX_-_48326764 | 4.38 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
chr1_-_6545502 | 4.21 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr19_+_35739631 | 4.07 |
ENST00000602003.1
ENST00000360798.3 ENST00000354900.3 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr19_+_35606692 | 3.98 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr6_+_31895467 | 3.95 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr1_+_35225339 | 3.83 |
ENST00000339480.1
|
GJB4
|
gap junction protein, beta 4, 30.3kDa |
chr1_-_17307173 | 3.78 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr9_+_35673853 | 3.76 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
chr12_-_52911718 | 3.65 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr14_-_75422280 | 3.64 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
chr6_+_30851205 | 3.59 |
ENST00000515881.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr19_+_35739897 | 3.55 |
ENST00000605618.1
ENST00000427250.1 ENST00000601623.1 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_-_26197744 | 3.48 |
ENST00000374296.3
|
PAQR7
|
progestin and adipoQ receptor family member VII |
chr1_-_6546001 | 3.46 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr1_-_153363452 | 3.37 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr6_+_31895480 | 3.36 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr1_+_2407754 | 3.31 |
ENST00000419816.2
ENST00000378486.3 ENST00000378488.3 ENST00000288766.5 |
PLCH2
|
phospholipase C, eta 2 |
chr5_-_141257954 | 3.30 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
chr19_-_51487282 | 3.30 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr17_-_39677971 | 3.29 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
chr5_-_149792295 | 3.21 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr4_-_90758227 | 3.20 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr2_+_233925064 | 3.18 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr7_+_144052381 | 3.16 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chr17_+_7255208 | 3.11 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
chr4_+_4388805 | 3.10 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr1_+_86889769 | 3.06 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
chr19_+_35739782 | 2.96 |
ENST00000347609.4
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_+_209602156 | 2.93 |
ENST00000429156.1
ENST00000366437.3 ENST00000603283.1 ENST00000431096.1 |
MIR205HG
|
MIR205 host gene (non-protein coding) |
chrX_+_48367338 | 2.89 |
ENST00000359882.4
ENST00000537758.1 ENST00000367574.4 ENST00000355961.4 ENST00000489940.1 ENST00000361988.3 |
PORCN
|
porcupine homolog (Drosophila) |
chr6_+_36098262 | 2.85 |
ENST00000373761.6
ENST00000373766.5 |
MAPK13
|
mitogen-activated protein kinase 13 |
chr7_-_143991230 | 2.81 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr11_+_123986069 | 2.79 |
ENST00000456829.2
ENST00000361352.5 ENST00000449321.1 ENST00000392748.1 ENST00000360334.4 ENST00000392744.4 |
VWA5A
|
von Willebrand factor A domain containing 5A |
chr14_+_95078714 | 2.78 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chrX_-_48326683 | 2.78 |
ENST00000440085.1
|
SLC38A5
|
solute carrier family 38, member 5 |
chr19_+_50084561 | 2.75 |
ENST00000246794.5
|
PRRG2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
chr17_-_5487768 | 2.73 |
ENST00000269280.4
ENST00000345221.3 ENST00000262467.5 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr17_+_7341586 | 2.71 |
ENST00000575235.1
|
FGF11
|
fibroblast growth factor 11 |
chr11_-_119999611 | 2.70 |
ENST00000529044.1
|
TRIM29
|
tripartite motif containing 29 |
chr19_-_11688260 | 2.68 |
ENST00000590832.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chr2_-_113594279 | 2.63 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr6_-_32634425 | 2.62 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr6_-_31846744 | 2.58 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr11_-_119999539 | 2.57 |
ENST00000541857.1
|
TRIM29
|
tripartite motif containing 29 |
chr21_-_42879909 | 2.54 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
chr19_-_51456198 | 2.53 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
chr16_+_68678892 | 2.52 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr12_-_54778471 | 2.50 |
ENST00000550120.1
ENST00000394313.2 ENST00000547210.1 |
ZNF385A
|
zinc finger protein 385A |
chr19_-_51456344 | 2.49 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr17_-_39928106 | 2.49 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
chr14_+_24867992 | 2.47 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr6_+_30850697 | 2.46 |
ENST00000509639.1
ENST00000412274.2 ENST00000507901.1 ENST00000507046.1 ENST00000437124.2 ENST00000454612.2 ENST00000396342.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr19_-_51456321 | 2.46 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr2_+_220325977 | 2.44 |
ENST00000396686.1
ENST00000396689.2 |
SPEG
|
SPEG complex locus |
chr12_+_122356488 | 2.40 |
ENST00000397454.2
|
WDR66
|
WD repeat domain 66 |
chr19_+_45281118 | 2.39 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr19_-_12912657 | 2.39 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
chr21_-_28215332 | 2.39 |
ENST00000517777.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr17_-_39681578 | 2.36 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr3_-_46735155 | 2.36 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
chr1_+_150480551 | 2.35 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr6_+_43044003 | 2.34 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
chr6_+_30850862 | 2.33 |
ENST00000504651.1
ENST00000512694.1 ENST00000515233.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr5_+_15500280 | 2.30 |
ENST00000504595.1
|
FBXL7
|
F-box and leucine-rich repeat protein 7 |
chr15_+_41136734 | 2.30 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr1_-_6550625 | 2.29 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr16_-_30102547 | 2.29 |
ENST00000279386.2
|
TBX6
|
T-box 6 |
chr6_+_30851840 | 2.29 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr2_+_223289208 | 2.27 |
ENST00000321276.7
|
SGPP2
|
sphingosine-1-phosphate phosphatase 2 |
chr6_-_10419871 | 2.26 |
ENST00000319516.4
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr5_-_142077569 | 2.24 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr16_-_31146961 | 2.24 |
ENST00000567531.1
|
PRSS8
|
protease, serine, 8 |
chr4_-_10041872 | 2.23 |
ENST00000309065.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr11_-_87908600 | 2.22 |
ENST00000531138.1
ENST00000526372.1 ENST00000243662.6 |
RAB38
|
RAB38, member RAS oncogene family |
chr16_-_65155833 | 2.21 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr6_+_30848557 | 2.21 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr1_+_152881014 | 2.19 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr14_+_94640633 | 2.17 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr11_-_62446527 | 2.16 |
ENST00000294119.2
ENST00000529640.1 ENST00000534176.1 ENST00000301935.5 |
UBXN1
|
UBX domain protein 1 |
chr8_-_143867946 | 2.16 |
ENST00000301263.4
|
LY6D
|
lymphocyte antigen 6 complex, locus D |
chr20_+_36531499 | 2.16 |
ENST00000373458.3
ENST00000373461.4 ENST00000373459.4 |
VSTM2L
|
V-set and transmembrane domain containing 2 like |
chr20_-_44540686 | 2.16 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
chr14_+_23305783 | 2.15 |
ENST00000547279.1
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
chr1_-_159915386 | 2.14 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
chr19_+_45971246 | 2.13 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr6_+_106959718 | 2.11 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
chr3_-_13921594 | 2.10 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
chr14_-_24809154 | 2.10 |
ENST00000216274.5
|
RIPK3
|
receptor-interacting serine-threonine kinase 3 |
chr14_-_65569244 | 2.09 |
ENST00000557277.1
ENST00000556892.1 |
MAX
|
MYC associated factor X |
chr16_+_84402098 | 2.07 |
ENST00000262429.4
ENST00000416219.2 |
ATP2C2
|
ATPase, Ca++ transporting, type 2C, member 2 |
chr19_+_35739597 | 2.07 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_+_152974218 | 2.05 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
chr1_+_20915409 | 2.04 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
chr1_-_161008697 | 2.04 |
ENST00000318289.10
ENST00000368023.3 ENST00000368024.1 ENST00000423014.2 |
TSTD1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr18_-_28682374 | 2.03 |
ENST00000280904.6
|
DSC2
|
desmocollin 2 |
chr11_+_313503 | 2.01 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr5_-_131563474 | 1.99 |
ENST00000417528.1
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chrX_+_43515467 | 1.98 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chr5_+_3596168 | 1.98 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
chr17_-_39674668 | 1.98 |
ENST00000393981.3
|
KRT15
|
keratin 15 |
chr11_+_35222629 | 1.97 |
ENST00000526553.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr12_-_54778444 | 1.96 |
ENST00000551771.1
|
ZNF385A
|
zinc finger protein 385A |
chr16_+_30662360 | 1.95 |
ENST00000542965.2
|
PRR14
|
proline rich 14 |
chr19_+_16177826 | 1.94 |
ENST00000589897.1
|
TPM4
|
tropomyosin 4 |
chr19_-_41934635 | 1.94 |
ENST00000321702.2
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
chr11_-_104916034 | 1.92 |
ENST00000528513.1
ENST00000375706.2 ENST00000375704.3 |
CARD16
|
caspase recruitment domain family, member 16 |
chr6_-_31550192 | 1.92 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr17_-_5487277 | 1.91 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr4_+_74735102 | 1.90 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr14_-_21270995 | 1.89 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr4_-_57522673 | 1.88 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr18_+_61420169 | 1.87 |
ENST00000425392.1
ENST00000336429.2 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr21_-_42880075 | 1.86 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
chr1_-_28503693 | 1.85 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chr19_-_11688500 | 1.84 |
ENST00000433365.2
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chr11_+_12302492 | 1.83 |
ENST00000533534.1
|
MICALCL
|
MICAL C-terminal like |
chr15_+_41136369 | 1.81 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr13_+_43597269 | 1.80 |
ENST00000379221.2
|
DNAJC15
|
DnaJ (Hsp40) homolog, subfamily C, member 15 |
chr8_-_139926236 | 1.79 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
chr6_+_35265586 | 1.79 |
ENST00000542066.1
ENST00000316637.5 |
DEF6
|
differentially expressed in FDCP 6 homolog (mouse) |
chr20_-_43977055 | 1.76 |
ENST00000372733.3
ENST00000537976.1 |
SDC4
|
syndecan 4 |
chr16_+_55522536 | 1.76 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr11_-_67442079 | 1.76 |
ENST00000349015.3
|
ALDH3B2
|
aldehyde dehydrogenase 3 family, member B2 |
chr20_-_43883197 | 1.75 |
ENST00000338380.2
|
SLPI
|
secretory leukocyte peptidase inhibitor |
chr19_-_52552051 | 1.74 |
ENST00000221315.5
|
ZNF432
|
zinc finger protein 432 |
chr18_-_61089611 | 1.74 |
ENST00000591519.1
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae) |
chr22_-_31688381 | 1.72 |
ENST00000487265.2
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr11_+_118477144 | 1.71 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
chr15_-_75017711 | 1.70 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
chr6_-_43596899 | 1.70 |
ENST00000307126.5
ENST00000452781.1 |
GTPBP2
|
GTP binding protein 2 |
chr17_+_7348658 | 1.69 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
chr17_+_7284365 | 1.69 |
ENST00000311668.2
|
TNK1
|
tyrosine kinase, non-receptor, 1 |
chr3_-_187455680 | 1.67 |
ENST00000438077.1
|
BCL6
|
B-cell CLL/lymphoma 6 |
chrX_+_102469997 | 1.67 |
ENST00000372695.5
ENST00000372691.3 |
BEX4
|
brain expressed, X-linked 4 |
chr6_+_30848829 | 1.67 |
ENST00000508317.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr3_-_48632593 | 1.66 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
chr22_+_19744226 | 1.66 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
chr6_+_18387570 | 1.66 |
ENST00000259939.3
|
RNF144B
|
ring finger protein 144B |
chr6_+_54711533 | 1.65 |
ENST00000306858.7
|
FAM83B
|
family with sequence similarity 83, member B |
chr14_+_24837226 | 1.65 |
ENST00000554050.1
ENST00000554903.1 ENST00000554779.1 ENST00000250373.4 ENST00000553708.1 |
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
chr19_-_35323762 | 1.64 |
ENST00000590963.1
|
CTC-523E23.4
|
CTC-523E23.4 |
chr4_-_87515202 | 1.64 |
ENST00000502302.1
ENST00000513186.1 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr17_-_34122596 | 1.62 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr11_-_111794446 | 1.61 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr14_+_94640671 | 1.61 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr1_+_156024552 | 1.61 |
ENST00000368304.5
ENST00000368302.3 |
LAMTOR2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
chr12_+_57522258 | 1.61 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr1_-_17304771 | 1.61 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr11_-_102668879 | 1.60 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr5_+_170210721 | 1.60 |
ENST00000265294.4
ENST00000519385.1 ENST00000519598.1 |
GABRP
|
gamma-aminobutyric acid (GABA) A receptor, pi |
chr1_+_36772691 | 1.59 |
ENST00000312808.4
ENST00000505871.1 |
SH3D21
|
SH3 domain containing 21 |
chr1_-_27286897 | 1.59 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr2_+_88469835 | 1.59 |
ENST00000358591.2
ENST00000377254.3 ENST00000402102.1 ENST00000419759.1 ENST00000449349.1 ENST00000343544.4 |
THNSL2
|
threonine synthase-like 2 (S. cerevisiae) |
chr19_+_2867325 | 1.58 |
ENST00000307635.2
ENST00000586426.1 |
ZNF556
|
zinc finger protein 556 |
chr11_+_129245796 | 1.57 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
chr17_+_48609903 | 1.57 |
ENST00000268933.3
|
EPN3
|
epsin 3 |
chr14_+_24630465 | 1.56 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr14_+_70078303 | 1.56 |
ENST00000342745.4
|
KIAA0247
|
KIAA0247 |
chr6_+_30848771 | 1.56 |
ENST00000503180.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr3_-_195538760 | 1.56 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr4_+_89514402 | 1.55 |
ENST00000426683.1
|
HERC3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
chr8_+_13424352 | 1.55 |
ENST00000297324.4
|
C8orf48
|
chromosome 8 open reading frame 48 |
chr6_+_36097992 | 1.55 |
ENST00000211287.4
|
MAPK13
|
mitogen-activated protein kinase 13 |
chr19_-_2042065 | 1.55 |
ENST00000591588.1
ENST00000591142.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr1_+_44401479 | 1.54 |
ENST00000438616.3
|
ARTN
|
artemin |
chr15_-_45459704 | 1.54 |
ENST00000558039.1
|
CTD-2651B20.1
|
CTD-2651B20.1 |
chr8_+_145065521 | 1.52 |
ENST00000534791.1
|
GRINA
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
chr3_-_185538849 | 1.51 |
ENST00000421047.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr1_+_159931002 | 1.51 |
ENST00000443364.1
ENST00000423943.1 |
RP11-48O20.4
|
long intergenic non-protein coding RNA 1133 |
chr11_+_44587206 | 1.51 |
ENST00000525210.1
ENST00000527737.1 ENST00000524704.1 |
CD82
|
CD82 molecule |
chr6_+_30848740 | 1.50 |
ENST00000505534.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr5_+_9546306 | 1.50 |
ENST00000508179.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
chr1_-_230561475 | 1.50 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
chr4_-_90757364 | 1.50 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr1_+_202995611 | 1.50 |
ENST00000367240.2
|
PPFIA4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
chr19_+_45973120 | 1.49 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr6_+_44095347 | 1.49 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
chr22_+_40390930 | 1.49 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
chr19_+_48281842 | 1.48 |
ENST00000509570.2
|
SEPW1
|
selenoprotein W, 1 |
chr11_-_57089671 | 1.47 |
ENST00000532437.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr8_+_145065705 | 1.47 |
ENST00000533044.1
|
GRINA
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
chr19_-_49565254 | 1.46 |
ENST00000593537.1
|
NTF4
|
neurotrophin 4 |
chr8_+_22437664 | 1.45 |
ENST00000436754.1
ENST00000426493.1 ENST00000429812.1 |
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
chr16_-_67260691 | 1.45 |
ENST00000447579.1
ENST00000393992.1 ENST00000424285.1 |
LRRC29
|
leucine rich repeat containing 29 |
chr1_+_44115814 | 1.45 |
ENST00000372396.3
|
KDM4A
|
lysine (K)-specific demethylase 4A |
chr17_-_39661947 | 1.44 |
ENST00000590425.1
|
KRT13
|
keratin 13 |
chr16_+_55512742 | 1.44 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr3_-_48601206 | 1.44 |
ENST00000273610.3
|
UCN2
|
urocortin 2 |
chr19_-_49568311 | 1.43 |
ENST00000595857.1
ENST00000451356.2 |
NTF4
|
neurotrophin 4 |
chr4_+_2794750 | 1.43 |
ENST00000452765.2
ENST00000389838.2 |
SH3BP2
|
SH3-domain binding protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 12.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
2.0 | 21.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.8 | 10.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.5 | 4.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
1.3 | 7.7 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
1.1 | 3.3 | GO:0035698 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
1.0 | 18.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.0 | 2.9 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.9 | 2.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.8 | 2.5 | GO:1904597 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.8 | 5.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.8 | 6.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 7.3 | GO:1990834 | response to odorant(GO:1990834) |
0.7 | 2.2 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.7 | 2.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.7 | 8.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 2.7 | GO:1903722 | negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
0.7 | 2.7 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.6 | 2.5 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.6 | 3.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.6 | 1.8 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.6 | 5.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 1.7 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.6 | 1.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.6 | 1.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 1.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.5 | 0.5 | GO:0001819 | positive regulation of cytokine production(GO:0001819) |
0.5 | 2.1 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.5 | 15.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 2.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 2.0 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.5 | 5.9 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.5 | 2.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 10.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 2.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 2.3 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.5 | 1.4 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.4 | 0.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.4 | 2.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 2.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 1.3 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.4 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
0.4 | 1.7 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 2.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 1.2 | GO:2000981 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.4 | 4.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 4.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 2.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 2.4 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 3.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.4 | 1.9 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 1.1 | GO:0015920 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) lipopolysaccharide transport(GO:0015920) |
0.4 | 1.1 | GO:2000282 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.4 | 1.9 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.4 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 4.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.1 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.3 | 2.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 1.0 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.3 | 1.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.3 | 1.3 | GO:0018277 | protein deamination(GO:0018277) |
0.3 | 1.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.3 | GO:0032672 | response to molecule of fungal origin(GO:0002238) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
0.3 | 1.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 8.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 1.0 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.3 | 4.8 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.3 | 2.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.9 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 5.7 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 1.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 0.9 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 0.9 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.3 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 0.9 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.3 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.3 | 0.9 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 2.7 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.3 | 1.8 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 1.2 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.3 | 4.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 2.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 0.9 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.3 | 0.9 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.3 | 0.9 | GO:0086044 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
0.3 | 0.8 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
0.3 | 1.7 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.3 | 0.8 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.3 | 1.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.8 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.3 | 0.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.8 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.3 | 1.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 2.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 3.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 1.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.3 | 1.0 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.2 | 9.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 2.7 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.2 | 1.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 2.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 1.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 0.5 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 1.4 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.2 | 3.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.7 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.2 | 1.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.2 | 1.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 1.3 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.2 | 7.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 2.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 3.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.6 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.2 | 2.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 1.0 | GO:0032796 | uropod organization(GO:0032796) |
0.2 | 0.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 0.6 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.2 | 5.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 4.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 0.8 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.2 | 2.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.2 | 1.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 1.3 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.6 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.2 | 2.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.9 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.2 | 1.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 3.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 1.9 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 1.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.2 | 2.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 2.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 3.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 4.0 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.2 | 0.8 | GO:0033590 | response to cobalamin(GO:0033590) |
0.2 | 1.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 4.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 14.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 2.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 1.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.2 | 0.9 | GO:0006574 | valine catabolic process(GO:0006574) |
0.2 | 0.8 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.9 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.2 | 1.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.7 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 1.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 2.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 1.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 1.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.7 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 1.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.3 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.1 | 0.6 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.3 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.1 | 1.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 1.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.9 | GO:0097319 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.1 | 0.5 | GO:0051944 | orbitofrontal cortex development(GO:0021769) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.4 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 3.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 1.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 1.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.6 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.6 | GO:1900756 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) protein processing in phagocytic vesicle(GO:1900756) regulation of plasma membrane raft polarization(GO:1903906) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 1.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 1.9 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 1.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.6 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.1 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 3.2 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.6 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 1.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 2.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.1 | 0.4 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 1.3 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.1 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 1.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 1.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.3 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.7 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 1.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.1 | 3.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 1.0 | GO:1903764 | cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) regulation of potassium ion export across plasma membrane(GO:1903764) |
0.1 | 0.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 2.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 2.0 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.2 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.1 | 0.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 1.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.2 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
0.1 | 1.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 1.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 1.8 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 1.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 1.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 1.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 0.7 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 1.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 2.3 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 1.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.3 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.1 | 1.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 2.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
0.1 | 0.2 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.1 | 0.6 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.2 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 3.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0071322 | cellular response to carbohydrate stimulus(GO:0071322) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 11.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 1.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.1 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 2.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 1.0 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.7 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.7 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.1 | GO:2000523 | negative regulation of T-helper 1 cell differentiation(GO:0045626) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 2.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.4 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 6.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.5 | GO:2001268 | urokinase plasminogen activator signaling pathway(GO:0038195) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:2001021 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.1 | 0.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.1 | 0.7 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 1.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.4 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.1 | 0.4 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 1.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.2 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.1 | 0.1 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.1 | 1.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 1.4 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.1 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 0.2 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 1.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.3 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 1.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.9 | GO:0009607 | response to biotic stimulus(GO:0009607) |
0.1 | 0.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 1.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 2.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.0 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 1.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.2 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 1.1 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.2 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.0 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 3.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 1.9 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.1 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.0 | 1.8 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 0.3 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.0 | 0.2 | GO:1904396 | regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
0.0 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.8 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 1.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 1.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.2 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.0 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.1 | GO:2000611 | thyroid-stimulating hormone secretion(GO:0070460) positive regulation of thyroid hormone generation(GO:2000611) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.0 | 0.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 4.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 3.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.4 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.6 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.0 | 0.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.8 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.2 | GO:0015908 | fatty acid transport(GO:0015908) |
0.0 | 0.2 | GO:0000720 | meiotic mismatch repair(GO:0000710) pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.2 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.6 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 3.9 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 1.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.9 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 2.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.3 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.1 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.0 | 0.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 1.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 1.0 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.6 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.0 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 2.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.8 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:0045981 | regulation of cyclic nucleotide metabolic process(GO:0030799) positive regulation of nucleotide metabolic process(GO:0045981) positive regulation of purine nucleotide metabolic process(GO:1900544) |
0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.2 | GO:2001168 | positive regulation of mRNA binding(GO:1902416) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.0 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.8 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 1.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.9 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.7 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
0.0 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 1.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.5 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.4 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.9 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.2 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.2 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 1.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.9 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 1.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.4 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.0 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
0.0 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 1.3 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 2.5 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.1 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 1.1 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 1.0 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 1.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.6 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 10.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.0 | 12.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 2.4 | GO:0001534 | radial spoke(GO:0001534) |
0.8 | 6.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.7 | 2.9 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.7 | 4.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.6 | 7.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 5.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.5 | 3.0 | GO:0032044 | DSIF complex(GO:0032044) |
0.5 | 2.8 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.4 | 1.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 2.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 2.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.4 | 2.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.4 | 1.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 1.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 2.4 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 0.9 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.3 | 2.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 0.3 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.3 | 0.8 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.5 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 5.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.8 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 0.6 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 19.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 4.6 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.3 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 12.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 3.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 15.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 5.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 1.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 3.9 | GO:0043034 | costamere(GO:0043034) |
0.1 | 4.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 3.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 21.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 2.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 2.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 6.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.5 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 1.2 | GO:1904949 | ATP-binding cassette (ABC) transporter complex(GO:0043190) ATPase complex(GO:1904949) |
0.1 | 1.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 5.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.4 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 2.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.0 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 3.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 5.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 2.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 6.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 1.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 1.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 4.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 4.7 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 2.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 2.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.2 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 3.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 9.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 3.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 2.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 2.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 4.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 2.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 1.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 8.4 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 2.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 3.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 8.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 2.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 1.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 5.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.5 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.3 | GO:0035579 | specific granule membrane(GO:0035579) specific granule(GO:0042581) |
0.0 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 19.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.3 | 19.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.2 | 5.9 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.1 | 3.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.0 | 2.9 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.9 | 2.7 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.9 | 2.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.8 | 2.5 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.7 | 2.9 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.6 | 1.9 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.6 | 1.8 | GO:0032093 | SAM domain binding(GO:0032093) |
0.6 | 2.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 3.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.5 | 3.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 3.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 1.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 2.0 | GO:1990175 | EH domain binding(GO:1990175) |
0.5 | 2.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.5 | 1.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.5 | 5.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 1.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 2.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.4 | 1.3 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.4 | 3.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 3.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 2.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 1.1 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.4 | 5.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.4 | 2.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.4 | 1.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 3.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.3 | 1.7 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 1.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.3 | 12.6 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 2.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 2.9 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.3 | 1.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.5 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.3 | 1.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 4.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 0.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.3 | 0.9 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.3 | 0.8 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.8 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 5.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 2.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.2 | 1.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.2 | 2.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 3.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 2.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 6.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 0.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 0.6 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 3.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
0.2 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 15.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 2.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 3.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 5.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 2.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 2.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 3.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.0 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.2 | 1.8 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 3.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.9 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.2 | 1.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.5 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.2 | 0.5 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.1 | 0.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 1.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 1.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 3.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 1.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 3.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 1.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.6 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 17.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 31.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 6.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 2.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 2.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 1.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 1.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 4.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 3.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 2.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.1 | 0.4 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.7 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 2.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 3.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.9 | GO:1900750 | oligopeptide binding(GO:1900750) |
0.1 | 5.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.4 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 2.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 13.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.7 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 2.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 4.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 1.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 6.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 2.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 2.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 6.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.0 | 1.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0052726 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.0 | 1.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 1.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.7 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.2 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.0 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 1.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 4.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 3.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 9.9 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 1.1 | GO:0016791 | phosphatase activity(GO:0016791) |
0.0 | 0.1 | GO:0030545 | receptor regulator activity(GO:0030545) acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.0 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 2.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 1.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 2.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 1.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0072545 | tyrosine binding(GO:0072545) |
0.0 | 0.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.0 | 0.2 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 4.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 8.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 13.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 14.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 9.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 7.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 8.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 19.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 6.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 5.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 4.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.6 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 4.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 7.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 4.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 3.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 4.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 11.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 3.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 4.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 11.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 2.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 2.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 10.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 13.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 13.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 5.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 4.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 3.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 4.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 2.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 5.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 4.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 4.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 7.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 2.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 3.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 2.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 6.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 4.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 5.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 4.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 5.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 2.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 1.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |